HERVolution Advances Immune Therapy for Metabolic Disease
COPENHAGEN, Denmark and NEW YORK, June 10, 2026 HERVolution Therapeutics has announced compelling preclinical proof-of-concept data demonstrating the potential...
artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology NSCLC Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
COPENHAGEN, Denmark and NEW YORK, June 10, 2026 HERVolution Therapeutics has announced compelling preclinical proof-of-concept data demonstrating the potential...
LONDON, United Kingdom, June 8, 2026 Smith+Nephew has announced the successful completion of the first clinical procedures using its...
